Companies: 10,795·Total market cap: $144.5T
Strategic Partners A/S

Strategic Partners A/S

OZYMFOTCHealthcare● Active
$90.00
+$0.00(+0.00%)
Market Cap$3721410
P/E Ratio
52W High$90
52W Low$0.09
Overview

Strategic Partners A/S (OZYMF) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

ozymf · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Strategic Partners A/S (OZYMF) measures how much investors pay for each dollar of the company's trailing earnings. OZYMF's current PE ratio of N/A is calculated by dividing its stock price of $90.00 by its TTM earnings per share of -$20.59.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
0.00x
FY2025 est. EPS $81166.55
Based on 1 analyst
EPS (TTM)
-$20.59
TTM · diluted EPS
PEG Ratio
-1.05
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Strategic Partners A/S SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2014 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Strategic Partners A/S
Strategic Partners A/SYou
OZYMF
$4MN/A-$20.59
Evelo Biosciences, Inc.
Evelo Biosciences, Inc.
EVLO
$0MN/A-$26.28
HEALTHeUNIVERSE, Inc.
HEALTHeUNIVERSE, Inc.
HLUN
$0MN/A
NanoLogix, Inc.
NanoLogix, Inc.
NNLX
$0MN/A-$0.01
PaxMedica, Inc. Common Stock
PaxMedica, Inc. Common Stock
PXMD
$0MN/A-$11.00
Q BioMed Inc.
Q BioMed Inc.
QBIO
$0MN/A-$0.05
SmileDirectClub, Inc.
SmileDirectClub, Inc.
SDCCQ
$0MN/A-$0.71

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 13 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-20.59
2024-12-31
FY2024
$-0.00
2023-12-31
FY2023
$-0.74
2022-12-31
FY2022
$-3.14
2021-12-31
FY2021
$-17.94
2020-12-31
FY2020
$-22.32
2019-12-31
FY2019
$-16.87
2018-12-31
FY2018
$-11.47
2017-12-31
FY2017
$-10.43
2016-12-31
FY2016
$-5.89

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Strategic Partners A/S (OZYMF) measures how much investors pay for each dollar of the company's trailing earnings. OZYMF's current PE ratio of N/A is calculated by dividing its stock price of $90.00 by its TTM earnings per share of -$20.59.

PE Ratio = Stock Price ÷ EPS (TTM)
= $90.00 ÷ -$20.59 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

OZYMF pe ratio · 6 questions

OZYMF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $90.00 and TTM EPS of -$20.59. Data sourced from Financial Modeling Prep via OZYMF's SEC 10-K and 10-Q filings.

OZYMF PE ratioWhat is OZYMF PE ratioCurrent PE ratio of OZYMFOZYMF PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Strategic Partners A/S SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09